SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-14-150916
Filing Date
2014-04-21
Accepted
2014-04-21 16:59:06
Documents
2
Group Members
ALAN G. SPOONJONATHAN A. FLINTPOLARIS VENTURE MANAGEMENT CO. IV, L.L.C.POLARIS VENTURE PARTNERS ENTREPRENEURS' FUND IV, L.P.TERRANCE G. MCGUIRE

Document Format Files

Seq Description Document Type Size
1 SC 13D d715443dsc13d.htm SC 13D 114711
2 EX-A d715443dex99a.htm EX-99.A 7660
  Complete submission text file 0001193125-14-150916.txt   124186
Mailing Address 1000 WINTER STREET SUITE 3350 WALTHAM MA 02451
Business Address 1000 WINTER STREET SUITE 3350 WALTHAM MA 024511215 7812900770
POLARIS VENTURE PARTNERS IV LP (Filed by) CIK: 0001157864 (see all company filings)

IRS No.: 043571023 | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 840 MEMORIAL DRIVE 5TH FLOOR Cambridge MA 02139
Business Address 840 MEMORIAL DRIVE 5TH FLOOR Cambridge MA 02139 617-551-9600
Cerulean Pharma Inc. (Subject) CIK: 0001401914 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88094 | Film No.: 14774287
SIC: 2834 Pharmaceutical Preparations